Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer

Molecular Cancer Research

Volumn 13, Issue 1, 2015, Pages 161-173

  Puig, Marta ^a,b   Lugo, Roberto ^a   Gabasa, Marta ^a   Giménez, Alícia ^a   Velásquez, Adriana ^a   Galgoczy, Roland ^a   Ramírez, Josep ^c   Gomez Caro ^c   Busnadiego, Óscar ^d   Rodríguez Pascual, Fernando ^d   Gascón, Pere ^b   Reguart, Noemí ^b   Alcaraz, Jordi ^a,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d CSIC   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; CULTURE MEDIUM; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL DENSITY; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL SPREADING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG COMPLIANCE; LUNG PARENCHYMA; MALE; MATRIX STIFFENING; MITOGENESIS; NON SMALL CELL LUNG CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED FIBROBLAST; WESTERN BLOTTING; ADENOCARCINOMA; BIOSYNTHESIS; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHARMACOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ANTIGENS, CD29; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CULTURE MEDIA; FIBROBLASTS; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM;

EID: 84921748996     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0155     Document Type: Article

References (48)

1. Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med 2011;32:703-40.
2. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2012;17:320-9.
3. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7.
4. Dvorak HF, Flier J, Frank H. Tumors - wounds that do not heal - similarities between tumor stroma generation and wound-healing. N Engl J Med 1986;315:1650-9.
5. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-49.
6. Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 2005;15:329-41.
7. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8:2912-23.
8. Kis K, Liu X, Hagood JS. Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 2011;13:e27.
9. Bremnes RM, Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R, et al. The role of tumor stroma in cancer progression and prognosis emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 2011;6:209-17.
10. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
11. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010;190:693-706.
12. Wang HB, Dembo M, Wang YL. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. Am J Physiol-Cell Physiol 2000;279:C1345-C50.
13. Grinnell F, Zhu MF, Carlson MA, Abrams JM. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 1999;248:608-19.
14. Alcaraz J, Mori H, Ghajar CM, Brownfield D, Galgoczy R, Bissell MJ. Collective epithelial cell invasion overcomes mechanical barriers of collagenous extracellular matrix by a narrow tube-like geometry and MMP14-dependent local softening. Integr Biol 2011;3:1153-66.
15. Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 2011;108:7160-5.
16. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891-906.
17. Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R, Oertle P, et al. The nanomechanical signature of breast cancer. Nat Nanotechnol 2012;7:757-65.
18. Gabasa M, Royo D, Molina-Molina M, Roca-Ferrer J, Pujols L, Picado C, et al. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2. PLoS ONE 2013;8:e65445.
19. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 2004;11:36-42.
20. Hartel M, di Mola FF, Gardini A, Zimmermann A, Di Sebastiano P, Guweidhi A, et al. Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 2004;28:818-25.
21. Marin-Corral J, Fontes CC, Pascual-Guardia S, Sanchez F, Olivan M, Argiles JM, et al. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal 2010;12:365-80.
22. Alcaraz J, Xu R, Mori H, Nelson CM, Mroue R, Spencer VA, et al. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J 2008;27:2829-38.
23. Acerbi I, Luque T, Gimenez A, Puig M, Reguart N, Farre R, et al. Integrin-specific mechanoresponses to compression and extension probed by cylindrical flat-ended AFM tips in lung cells. PLoS ONE 2012;7:e32261.
24. Lagares D, Busnadiego O, Garcia-Fernandez RA, Kapoor M, Liu S, Carter DE, et al. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum 2012;64:1653-64.
25. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol 2001;3:67-70.
26. Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 2009;8:589-95.
27. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005;8:241-54.
28. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-89.
29. Schwarz R, Colarusso L, Doty P. Maintenance of differentiation in primary cultures of avian tendon cells. Exp Cell Res 1976;102:63-71.
30. Roca-Cusachs P, Alcaraz J, Sunyer R, Samitier J, Farre R, Navajas D. Micropatterning of single endothelial cell shape reveals a tight coupling between nuclear volume in G1 and proliferation. Biophys J 2008;94:4984-95.
31. Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010;22:697-706.
32. Eckes B, Zweers MC, Zhang ZG, Hallinger R, Mauch C, Aumailley M, et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc 2006;11:66-72.
33. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo . Cancer Res 2006;66:1526-35.
34. Takada Y, Puzon W. Identification of a regulatory region of integrin-beta-1 subunit using activating and inhibiting antibodies. J Biol Chem 1993;268:17597-601.
35. Tokunou M, Niki T, Eguchi K, Iba S, Tsuda H, Yamada T, et al. c-MET expression in myofibroblasts - Role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 2001;158:1451-63.
36. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006;4:38.
37. Xia H, Nho RS, Kahm J, Kleidon J, Henke CA. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta(1) integrin viability signaling pathway. J Biol Chem 2004;279:33024-34.
38. Dalla Costa AP, Clemente CFMZ, Carvalho HF, Carvalheira JB, Nadruz W Jr, Franchini KG. FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex. Cardiovasc Res 2010;86:421-31.
39. Margadant C, Monsuur HN, Norman JC, Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol 2011;23:607-14.
40. Bellis SL. Variant glycosylation: an underappreciated regulatory mechanism for beta 1 integrins. Biochim Biophys Acta 2004;1663:52-60.
41. Dingemans A-MC, van den Boogaart V, Vosse BA, van Suylen R-J, Griffioen AW, Thijssen VL. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer. Mol Cancer 2010;9:152.
42. Zhan J, Zhu X, Guo Y, Wang Y, Wang Y, Qiang G, et al. Opposite role of kindlin-1 and kindlin-2 in lung cancers. PLoS ONE 2012;7:e50313.
43. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A 1998;95:14821-6.
44. Planque C, Kulasingam V, Smith CR, Reckamp K, Goodglick L, Diamandis EP. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol Cell Proteomics 2009;8:2746-58.
45. Reck M, Kaiser R, Mellemgaard A, Douillard J-Y, Orlov S, Krzakowski M, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non- small cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 2014;15:143-55.
46. Mori T, Matsubara E, Fujino K, Shibata H, Yoshimoto K, Ikeda K, et al. Intratumor pressure of lung cancer may correlate tumor aggressiveness. J Thorac Oncol 2013;8:S429.
47. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 2010;16:1009-17.
48. Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011;19:776-91.